Clinical
Innovations, one of the largest medical device companies exclusively
focused on labor and delivery and the neonatal intensive care unit, has
acquired Brenner
Medical GmbH through its wholly owned subsidiary, Clinical
Innovations Europe. The acquisition in central Europe broadens Clinical
Innovations’ infrastructure in Europe and overall global presence. The
purchase will also provide a platform to improve product reach in
Germany, the continent’s largest economy.

“Brenner Medical has been a strong partner for many years, and together,
our devices allow clinicians to innovate and improve patient outcomes,”
said Steve Cash, senior vice president of global sales at Clinical
Innovations. “Brenner brings a network of world-class medical device
partners and we are eager to integrate those products with our portfolio
of complementary products for physicians and nurses.”

Clinical Innovations has consistently expanded its worldwide presence,
becoming the market leader in several product categories. The Brenner
Medical acquisition builds on the successful creation of Clinical
Innovations Europe, which was formed in 2014.

Brenner Medical was founded by owner Angelika Salomon in 1997 and offers
innovative products for the fields of obstetrics and gynecology.

“The acquisition of our German distributor allows the company to broaden
our commercial reach in a market where we have already enjoyed
significant commercial success. We anticipate continued growth
opportunities in this strategically important area of the world,” said
Ken Reali, president and CEO of Clinical Innovations. “We thank Ms.
Salomon for all she has done to support the care of mothers and babies
in the German market over the past twenty years,” added Mr. Reali.

“We are pleased to see Clinical Innovations continue to take steps to
enhance its commercial platform, and the Brenner Medical acquisition is
a significant step forward,” said Mike Lynch, operating partner at
Pritzker Group Private Capital.

Clinical Innovations is a member of the Pritzker Group’s family of
companies.

About Clinical Innovations

Clinical Innovations is one of the largest medical device companies
exclusively focused on labor and delivery and the neonatal intensive
care unit. The company is already a market leader in several categories
with products such as the Koala® Intrauterine Pressure
Catheter; Kiwi® Vacuum-Assisted Delivery System; ROM Plus®
Rupture of Membranes Test; traxi® Panniculus Retractor;
ClearView Uterine Manipulator; babyLance Safety Heelstick; and the
recently added ebb Complete Tamponade System.Clinical
Innovations is expanding its global presence while developing
state-of-the-art technologies and innovative medical devices that
fulfill its mission of improving the lives of mothers and their babies
throughout the world. Clinical Innovations is a Pritzker Group company.
For more information, visit clinicalinnovations.com.

About Pritzker Group

Pritzker Group, founded by Tony and J.B. Pritzker, has three principal
investment teams: Private Capital, which acquires and operates leading
North America-based companies; Venture Capital, which provides
early-stage and growth venture funding to technology companies
throughout the United States; and Asset Management, which partners with
top-performing investment managers across global public markets.

Pritzker Group Private Capital acquires North America-based
middle-market companies with leading positions in the manufactured
products, services and health care sectors. The firm’s permanent,
proprietary capital base allows for efficient decision making, broad
flexibility with transaction structure and investment horizon, and
alignment with management teams focused on creating long-term value.
Pritzker Group brings significant resources, expertise and credibility
in building businesses and is an ideal partner for entrepreneur- and
family-owned companies. For more information, visit pritzkergroup.com.